HALB News and Press, Tykhe Corp From 01/12/21

JACKSON CENTER, PA / ACCESSWIRE / January 12, 2021 / Halberd Corp. (OTC PINK: HALB ) was recently included alongside Novavax Inc and Moderna Inc in a recent Wall Street PR article on Covid-19 related stocks poised to have an impact in 2021. Halberd was noted to be working in a different ...

Both Senate seats went to Democrats and this allows for a blue agenda with cannabis legalization being one of the top priorities. Arizona's legalization of recreational cannabis is already being geared up for with companies retooling in preparation. The industry will see continued...

JACKSON CENTER, PA / ACCESSWIRE / January 4, 2021 / Greetings From The CEO And Staff At HALBERD CORPORATION ! (OTC PINK: HALB ). First of all I want to wish all of our shareholders and constituents a Very Healthy, Happy and Prosperous New Year! A LOOK BACK I have been working sin...

2020 saw increases of 80% in Canada and expectations are for that to double next year. California will lead revenue growth rates as the state continues to ramp up the industry. Washington and Colorado are starting to see overall growth rates slow modestly, excepting pandemic-induc...

Halberd's ([[HALB]] +8.2%) research has produced a second monoclonal antibody (mAb) against the Covid-19 spike protein after initial testing displayed a stronger affinity for the SARS-CoV-2 antigen than Halberd's initial antibody.Testing will continue on each antibody to establish potenc...

JACKSON CENTER, PA / ACCESSWIRE / December 23, 2020 / Halberd Corp. (OTC PINK: HALB ) research has produced a second monoclonal antibody (mAb) against the Covid-19 spike protein. Initial testing displays a stronger affinity for the SARS-CoV-2 antigen than Halberd's initial antibody. Testing ...

JACKSON CENTER, PA / ACCESSWIRE / December 17, 2020 / Halberd Corp. (OTC PINK: HALB ) announced they are pursuing development of their latest treatment variation in the fight against COVID-19. Halberd's provisional patent application, " Method For Treating And Curing Covid-19 Infection By Ut...

JACKSON CENTER, PA / ACCESSWIRE / December 14, 2020 / Halberd Corporation (OTC PINK: HALB ) announced its proprietary, highly potent, neutralizing antibody against SARS-CoV-2, which demonstrated very strong receptor specificity and inhibition of SARS-CoV-2 replication. Halberd's anti-Spike p...

Phoenix, Arizona--(Newsfile Corp. - December 10, 2020) - The Stock Day Podcast welcomed Halberd Corporation (OTC Pink: HALB) ("the Company"), a company with a patented extracorporeal treatment applicable to many hard-to-cure blood-borne and neurological diseases, including COVID-19, other viru...

JACKSON CENTER, PA / ACCESSWIRE / December 7, 2020 / Halberd Corporation (OTC PINK: HALB ) announced the promising results of laboratory testing on their new patent pending SARS-COV-2 monoclonal antibody generated through their university research. The antibody testing to date has shown extr...